Drug Related Deaths & Eligibility
Through this session, we will review key considerations in determining donor eligibility in death involving prescription and illicit drugs. In addition to the concern for RCDADs, we will evaluate implications on tissue quality and viability as a result of chronic and acute drug involvement and toxicity.
Gregory Ray, MD
Dr. Gregory Ray is the Medical Director at CryoLife in Kennesaw, GA. Dr. Ray is past Chair of the AATB Physicians’ Council, has served on the AATB Board of Governors, and is currently on the AATB Standards Committee. Dr. Ray received his B.S. degree in Biology from Oglethorpe University in Atlanta, GA and his M.D. degree from Medical College of Georgia in Augusta, GA. He completed a fellowship in Molecular Medicine at the Institute for Molecular Medicine and Genetics at MCG.
He completed postgraduate training in Anatomic Pathology and Laboratory Medicine and was Chief Resident at Emory University in 2000. Dr. Ray is certified by the American Board of Pathology in both Anatomic and Clinical Pathology, with a special interest in cardiovascular pathology. He is a fellow of the College of American Pathologists and a member of the Society of Cardiovascular Pathology. Prior to joining CryoLife in 2003, Dr. Ray served as Laboratory Medical Director and Staff Pathologist in four Atlanta area community hospitals.